Net Cash Provided by (Used in) Investing Activities of Aprea Therapeutics, Inc. from 31 Dec 2018 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Summary
Aprea Therapeutics, Inc. annual and quarterly Net Cash Provided by (Used in) Investing Activities in USD history and change rate from 31 Dec 2018 to 31 Dec 2024.
  • Aprea Therapeutics, Inc. Net Cash Provided by (Used in) Investing Activities for the quarter ending 31 Mar 2024 was $7,978.
  • Aprea Therapeutics, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2024 was $15,478, a 83% increase from 2023.
  • Aprea Therapeutics, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2023 was $93,093.
  • Aprea Therapeutics, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2020 was $25,709, a 17% increase from 2019.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Investing Activities, Annual (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Annual Change (%)
Net Cash Provided by (Used in) Investing Activities, Quarterly (USD)

Aprea Therapeutics, Inc. Annual Net Cash Provided by (Used in) Investing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $15,478 +$77,615 +83% 01 Jan 2024 31 Dec 2024 10-K 25 Mar 2025 2024 FY
2023 $93,093 01 Jan 2023 31 Dec 2023 10-K 25 Mar 2025 2024 FY
2020 $25,709 +$5,192 +17% 01 Jan 2020 31 Dec 2020 10-K 30 Mar 2023 2022 FY
2019 $30,901 -$27,199 -735% 01 Jan 2019 31 Dec 2019 10-K 15 Mar 2022 2021 FY
2018 $3,702 01 Jan 2018 31 Dec 2018 10-K 16 Mar 2021 2020 FY

Aprea Therapeutics, Inc. Quarterly Net Cash Provided by (Used in) Investing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $7,978 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025 2025 Q1
Q1 2020 $12,165 01 Jan 2020 31 Mar 2020 10-Q 06 May 2021 2021 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.